Literature DB >> 21397720

Lower peripheral blood CD14+ monocyte frequency and higher CD34+ progenitor cell frequency are associated with HBV vaccine induced response in HIV infected individuals.

D D Anthony1, T Umbleja, J A Aberg, M Kang, K Medvik, M M Lederman, M G Peters, M J Koziel, E T Overton.   

Abstract

We evaluated immunologic predictors of response to HBV vaccine administered in the presence or absence of GM-CSF in HIV infected individuals. We measured peripheral blood hematopoietic progenitor, monocyte and myeloid-derived suppressor cell (MDSC) frequencies, and expression of GMCSF receptor on monocytes and MDSCs, at baseline and 4weeks after immunization in relation to antibody response. We observed higher baseline progenitor and lower monocyte frequencies among week 16 antibody responders. Week 4 decline in MDSC frequency was associated with week 16 antibody response, while administration of GM-CSF was associated with preservation of these cells. No significant differences in GM-CSF receptor expression were observed in the presence vs. absence of GM-CSF. These findings are consistent with a positive role of progenitor cells and a potential negative role of monocytes in vaccine response. Additionally, GM-CSF augmented the preservation of peripheral blood MDSC, which may contribute to the lack of improved vaccine responses. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21397720      PMCID: PMC3081920          DOI: 10.1016/j.vaccine.2011.02.092

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  25 in total

1.  Characterization of hepatitis B virus surface antigen-specific CD4+ T cells in hepatitis B vaccine non-responders.

Authors:  T Suzuki; K Yamauchi; T Kuwata; N Hayashi
Journal:  J Gastroenterol Hepatol       Date:  2001-08       Impact factor: 4.029

2.  Hepatitis B immunization of healthy elderly adults: relationship between naïve CD4+ T cells and primary immune response and evaluation of GM-CSF as an adjuvant.

Authors:  R J Looney; M S Hasan; D Coffin; D Campbell; A R Falsey; J Kolassa; J M Agosti; G N Abraham; T G Evans
Journal:  J Clin Immunol       Date:  2001-01       Impact factor: 8.317

3.  Granulocyte macrophage colony stimulating factor (GM-CSF) induced sero-protection in end stage renal failure patients to hepatitis B in vaccine non-responders.

Authors:  R Jha; S Lakhtakia; M A Jaleel; G Narayan; K Hemlatha
Journal:  Ren Fail       Date:  2001-09       Impact factor: 2.606

Review 4.  Overview of the pathogenesis, prophylaxis and therapeusis of viral hepatitis B, with focus on reduction to practical applications.

Authors:  M R Hilleman
Journal:  Vaccine       Date:  2001-02-28       Impact factor: 3.641

5.  Response to immunization with recall and neoantigens after prolonged administration of an HIV-1 protease inhibitor-containing regimen. ACTG 375 team. AIDS Clinical Trials Group.

Authors:  H Valdez; K Y Smith; A Landay; E Connick; D R Kuritzkes; H Kessler; L Fox; J Spritzler; J Roe; M B Lederman; H M Lederman; T G Evans; M Heath-Chiozzi; M M Lederman
Journal:  AIDS       Date:  2000-01-07       Impact factor: 4.177

6.  Granulocyte-macrophage colony-stimulating factor enhances the efficacy of hepatitis B virus vaccine in previously unvaccinated haemodialysis patients.

Authors:  D Kapoor; S R Aggarwal; N P Singh; V Thakur; S K Sarin
Journal:  J Viral Hepat       Date:  1999-09       Impact factor: 3.728

7.  Nadir CD4+ T-cell count and numbers of CD28+ CD4+ T-cells predict functional responses to immunizations in chronic HIV-1 infection.

Authors:  Christoph G Lange; Michael M Lederman; Kathy Medvik; Robert Asaad; Mary Wild; Robert Kalayjian; Hernan Valdez
Journal:  AIDS       Date:  2003-09-26       Impact factor: 4.177

8.  Efficacy of granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant for hepatitis B virus in patients with HIV infection.

Authors:  Maria das Graças Sasaki; Roberto Foccacia; Iara J de Messias-Reason
Journal:  Vaccine       Date:  2003-11-07       Impact factor: 3.641

9.  Safety and immunogenicity of hepatitis A vaccine in human immunodeficiency virus-infected patients: a double-blind, randomized, placebo-controlled trial.

Authors:  Carol A Kemper; Richard Haubrich; Ian Frank; Gary Dubin; Charles Buscarino; J Allen McCutchan; Stanley C Deresinski
Journal:  J Infect Dis       Date:  2003-03-24       Impact factor: 5.226

10.  Immune response to hepatitis B vaccine in HIV-infected subjects using granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant: ACTG study 5220.

Authors:  E T Overton; M Kang; M G Peters; T Umbleja; B L Alston-Smith; B Bastow; D Demarco-Shaw; M J Koziel; L Mong-Kryspin; H L Sprenger; J Y Yu; J A Aberg
Journal:  Vaccine       Date:  2010-06-23       Impact factor: 3.641

View more
  11 in total

1.  Immune activation alters cellular and humoral responses to yellow fever 17D vaccine.

Authors:  Enoch Muyanja; Aloysius Ssemaganda; Pearline Ngauv; Rafael Cubas; Helene Perrin; Divya Srinivasan; Glenda Canderan; Benton Lawson; Jakub Kopycinski; Amanda S Graham; Dawne K Rowe; Michaela J Smith; Sharon Isern; Scott Michael; Guido Silvestri; Thomas H Vanderford; Erika Castro; Giuseppe Pantaleo; Joel Singer; Jill Gillmour; Noah Kiwanuka; Annet Nanvubya; Claudia Schmidt; Josephine Birungi; Josephine Cox; Elias K Haddad; Pontiano Kaleebu; Patricia Fast; Rafick-Pierre Sekaly; Lydie Trautmann; Denis Gaucher
Journal:  J Clin Invest       Date:  2014-06-09       Impact factor: 14.808

Review 2.  Reciprocal relationship between myeloid-derived suppressor cells and T cells.

Authors:  Srinivas Nagaraj; Je-In Youn; Dmitry I Gabrilovich
Journal:  J Immunol       Date:  2013-07-01       Impact factor: 5.422

Review 3.  Hepatitis B virus large surface protein: function and fame.

Authors:  Yuri Churin; Martin Roderfeld; Elke Roeb
Journal:  Hepatobiliary Surg Nutr       Date:  2015-02       Impact factor: 7.293

4.  Expansion of myeloid-derived suppressor cells promotes differentiation of regulatory T cells in HIV-1+ individuals.

Authors:  Ling Wang; Juan Zhao; Jun P Ren; Xiao Y Wu; Zheng D Morrison; Mohamed A Elgazzar; Shun B Ning; Jonathan P Moorman; Zhi Q Yao
Journal:  AIDS       Date:  2016-06-19       Impact factor: 4.177

5.  Optimized dosing of a CCR2 antagonist for amplification of vaccine immunity.

Authors:  Leah A Mitchell; Ryan J Hansen; Adam J Beaupre; Daniel L Gustafson; Steven W Dow
Journal:  Int Immunopharmacol       Date:  2012-12-13       Impact factor: 4.932

6.  Granulocyte-macrophage stimulating factor (GM-CSF) increases circulating dendritic cells but does not abrogate suppression of adaptive cellular immunity in patients with metastatic colorectal cancer receiving chemotherapy.

Authors:  Micaela Martinez; Nadia Ono; Marina Planutiene; Kestutis Planutis; Edward L Nelson; Randall F Holcombe
Journal:  Cancer Cell Int       Date:  2012-01-23       Impact factor: 5.722

Review 7.  Significant roles of regulatory T cells and myeloid derived suppressor cells in hepatitis B virus persistent infection and hepatitis B virus-related HCCs.

Authors:  Yasuteru Kondo; Tooru Shimosegawa
Journal:  Int J Mol Sci       Date:  2015-02-03       Impact factor: 5.923

8.  Long noncoding RNA HOTAIRM1 promotes myeloid-derived suppressor cell expansion and suppressive functions through up-regulating HOXA1 expression during latent HIV infection.

Authors:  Jinyu Zhang; Bal Krishna Chand Thakuri; Juan Zhao; Lam N Nguyen; Lam N T Nguyen; Dechao Cao; Xindi Dang; Sushant Khanal; Madison Schank; Zeyuan Lu; Xiao Y Wu; Zheng D Morrison; Mohamed El Gazzar; Zhengke Li; Yong Jiang; Shunbin Ning; Ling Wang; Jonathan P Moorman; Zhi Q Yao
Journal:  AIDS       Date:  2020-12-01       Impact factor: 4.632

9.  Monocytes from chronic HBV patients react in vitro to HBsAg and TLR by producing cytokines irrespective of stage of disease.

Authors:  Arjan Boltjes; Zwier M Groothuismink; Gertine W van Oord; Harry L A Janssen; Andrea M Woltman; André Boonstra
Journal:  PLoS One       Date:  2014-05-13       Impact factor: 3.240

Review 10.  The Role of Immune Cells in Chronic HBV Infection.

Authors:  Hai-Jun Li; Nai-Cui Zhai; Hong-Xiao Song; Yang Yang; An Cui; Tian-Yang Li; Zheng-Kun Tu
Journal:  J Clin Transl Hepatol       Date:  2015-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.